As of the latest SEC filings, APOGEE THERAPEUTICS INC (APGE) is held by 292 institutional funds. The largest fund shareholder is T. Rowe Price Capital Appreciation Fund (PACLX), holding an estimated $445,758,596.44 in market value, representing 0.67% of its portfolio.
Funds holding APOGEE THERAPEUTICS INC (APGE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- APGE
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.67% | $445,758,596.44 | 5,295,932 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $154,903,437.88 | 1,840,364 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.34% | $123,567,189.93 | 1,490,737 | Apr 30, 2026 | Jun 26, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.14% | $118,887,510.00 | 1,698,393 | Feb 28, 2026 | Apr 24, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.28% | $95,481,942.98 | 1,134,394 | Mar 31, 2026 | May 28, 2026 |
|
-
JNL/T. Rowe Price Capital Appreciation Fund
|
ETF | Independent / Boutique | 0.69% | $94,747,896.41 | 1,125,673 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.12% | $88,797,919.11 | 1,054,983 | Mar 31, 2026 | May 28, 2026 |
|
PAMCX
T. Rowe Price Mid-Cap Growth Fund, Inc.
|
MF | T. Rowe Price | 0.30% | $67,509,979.39 | 802,067 | Mar 31, 2026 | May 28, 2026 |
|
TCAF
T. Rowe Price Capital Appreciation Equity ETF
|
ETF | T. Rowe Price | 0.86% | $53,435,240.33 | 634,849 | Mar 31, 2026 | May 28, 2026 |
|
FBCHX
Fidelity Blue Chip Growth Fund
|
MF | Fidelity | 0.05% | $51,504,779.07 | 621,363 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.06% | $50,384,414.51 | 598,603 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 2.96% | $46,918,293.91 | 557,423 | Mar 31, 2026 | May 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.43% | $46,722,598.66 | 555,098 | Mar 31, 2026 | May 28, 2026 |
|
ITRIX
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO
|
MF | Voya | 0.67% | $44,088,161.83 | 523,799 | Mar 31, 2026 | Jun 1, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.20% | $43,979,444.64 | 530,576 | Apr 30, 2026 | Jun 26, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 1.97% | $37,519,246.71 | 452,639 | Apr 30, 2026 | Jun 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.11% | $36,466,212.15 | 439,935 | Apr 30, 2026 | Jun 26, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.15% | $35,828,100.00 | 511,830 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.16% | $34,567,820.00 | 493,826 | Feb 28, 2026 | Apr 24, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.61% | $31,951,605.36 | 379,608 | Mar 31, 2026 | May 29, 2026 |
|
-
Penn Series Flexibly Managed Fund
|
ETF | Independent / Boutique | 0.68% | $31,624,184.06 | 375,718 | Mar 31, 2026 | May 21, 2026 |
|
BBGSX
Bridge Builder Small/Mid Cap Growth Fund
|
MF | Independent / Boutique | 0.33% | $30,493,696.79 | 362,287 | Mar 31, 2026 | May 22, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.25% | $30,219,555.10 | 359,030 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.37% | $29,755,778.40 | 353,520 | Mar 31, 2026 | May 28, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 1.36% | $29,588,195.93 | 351,529 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)